Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
CHLSY Quote, Financials, Valuation and Earnings
Last price:
$10.58
Seasonality move
:
-35.3%
Day range:
$10.58 - $11.30
52-week range:
$10.05 - $14.32
Dividend yield:
1.45%
P/E ratio:
32.18x
P/S ratio:
4.17x
P/B ratio:
5.07x
Volume:
10.3K
Avg. volume:
23K
1-year change:
-17.15%
Market cap:
$24.4B
Revenue:
$5.8B
EPS (TTM):
$0.33
Earnings Data
Next earnings date for CHLSY
Jul 23
2025
Most recent earnings per share
--
Missed by --
(Dec 23/2024)
Consensus Estimate
--
(Dec 23/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CHLSY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
Chocoladefabriken Lindt & Spruengli AG Earnings Questions
-
How Much did Chocoladefabriken Lindt & Spruengli AG Generate in Revenue Last Quarter?
Chocoladefabriken Lindt & Spruengli AG reported -- worth of top line sales in its most recent quarter.
-
Did Chocoladefabriken Lindt & Spruengli AG Beat Earnings Last Quarter?
Chocoladefabriken Lindt & Spruengli AG announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Chocoladefabriken Lindt & Spruengli AG Profitable?
Chocoladefabriken Lindt & Spruengli AG reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Chocoladefabriken Lindt & Spruengli AG EPS Next Year?
Chocoladefabriken Lindt & Spruengli AG's earnings are forecast to grow from $0.32 per share to -- per share next year representing an increase of --.
-
When is Chocoladefabriken Lindt & Spruengli AG's Earnings Date?
Chocoladefabriken Lindt & Spruengli AG's next earnings date is July 23, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
